Sunday, November 8, 2026

USD/EUR Went Down By Over 2% In The Last 21 Sessions

ViaNews Editorial Team

August 23, 2024

USD/EUR Went Down By Over 2% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.5% for the last 21 sessions. At 23:10 EST on Thursday, 22 August, USD/EUR (USDEUR) is $0.90.

USD/EUR's yearly highs and lows, it's 0.257% up from its 52-week low and 6.102% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.29%, a negative 0.12%, and a positive 0.26%, respectively.

USD/EUR's highest amplitude of average volatility was 0.42% (last week), 0.30% (last month), and 0.26% (last quarter), respectively.

News about

  • Usd/jpy: clashing uncertainties – rabobank. According to FXStreet on Wednesday, 21 August, "That said, on a 6-month view, we continue to expect USD/JPY c assuming another BoJ rate hike, potentially around the turn of the year.", "Most activity in the last couple of weeks has been within the 145 to 147 area and there is a solid chance that this will continue to broadly hold USD/JPY in the near-term. "
  • Usd/jpy holds positive ground above 145.00 despite firmer fed rate cut expectations. According to FXStreet on Thursday, 22 August, "The USD/JPY pair trades on a stronger note around 145.35 during the early Asian session on Thursday. ", "The rising expectation of a Fed rate cut might weigh on the Greenback and cap the upside of USD/JPY in the near term. "
  • Usd/jpy price forecast: hovers around 145.20 post-fed minutes release. According to FXStreet on Wednesday, 21 August, "After falling to a seven-month low of 141.69, the USD/JPY recovered some ground and hit a two-week high of 149.39 before resuming its ongoing downtrend. ", "The USD/JPY trims some of its earlier gains after July's Federal Reserve's meeting minutes hinted the US central bank could ease policy as soon as September. "
  • According to FXStreet on Thursday, 22 August, "On the upside, the USD/JPY pair could encounter an immediate resistance at the downtrend line around the nine-day Exponential Moving Average (EMA) at the 146.45 level. ", "For support levels, the USD/JPY pair might navigate the region around the psychological level at 144.00 A break below this level could lead the pair to navigate the area around a seven-month low of 141.69, which was recorded on August 5. "
  • According to FXStreet on Wednesday, 21 August, "For support levels, the USD/JPY pair might navigate the region around the round numbers at 144.00 before 143.00 before a seven-month low of 141.69, which was recorded on August 5. ", "On the upside, the USD/JPY pair could encounter an immediate resistance at the downtrend line around the nine-day Exponential Moving Average (EMA) at the 146.80 level. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com